Progression of radiographic changes in the temporomandibular joints of patients with rheumatoid arthritis in relation to inflammatory markers and mediators in the blood

Acta Odontologica Scandinavica

Volumn 62, Issue 1, 2004, Pages 7-13

  Voog, Ülle ^a   Alstergren, Per ^b   Eliasson, Sören ^b   Leibur, Edvitar ^b   Kallikorm, Riina ^b   Kopp, Sigvard ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NONE

Author keywords

Computed tomography; Cytokines; Longitudinal study; Serotonin

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTHRITIS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE COURSE; ENZYME IMMUNOASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATION; LONGITUDINAL STUDY; MALE; RHEUMATOID ARTHRITIS; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDER;

ANTIGENS, CD; ARTHRITIS, RHEUMATOID; BLOOD PLATELETS; BLOOD SEDIMENTATION; BONE CYSTS; C-REACTIVE PROTEIN; DISEASE PROGRESSION; EXOSTOSES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OSTEOSCLEROSIS; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1 TYPE II; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SEROTONIN; SIALOGLYCOPROTEINS; TEMPOROMANDIBULAR JOINT DISORDERS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1642309355     PISSN: 00016357     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016350310007860     Document Type: Article

References (38)

1. Sharp JT. Radiologic assessment as an outcome measure in rheumatoid arthritis. Arthritis Rheum 1989;32:221-9.
2. Gordon P, West J, Jones H, Gibson T. A. 10-year prospective follow-up of patients with rheumatoid arthritis 1986-96. J Rheumatol 2001;28:2409-15.
3. Graudal NA, Jurik AG, de Carvalho A, Graudal HK. Radiographic progression in rheumatoid arthritis: a long-term prospective study of 109 patients. Arthritis Rheum 1998;41: 1470-80.
4. Uhlig T, Smedstad LM, Vaglum P, Moum T, Gerard N, Kvien TK. The course of rheumatoid arthritis and predictors of psychological, physical and radiographic outcome after 5 years of follow-up. Rheumatology (Oxf) 2001;39:732-41.
5. Vittecoq O, Pouplin S, Krzanowska K, Jouen-Beades F, Menard JF, Gayet A, et al. Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients. Rheumatology (Oxf) 2003;42:939-46.
6. Kaarela K. Prognostic factors and diagnostic criteria in early rheumatoid arthritis. Scand J Rheumatol 1985;57 Suppl: 1-54.
7. van der Heijde DM, van Riel PL, van Leeuwen MA, van't Hof MA, van Rijswijk MH, van de Putte LB. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Rheumatol 1992;31:519-25.
8. van Leeuwen MA, van Rijswijk MH, van der Heijde DM, Te Meerman GJ, van Riel PL, Houtman PM, et al. The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease. Br J Rheumatol 1993;32 Suppl 3:9-13.
9. Larsen A. The relation of radiographic changes to serum acute-phase proteins and rheumatoid factor in 200 patients with rheumatoid arthritis. Scand J Rheumatol 1988;17:123-9.
10. van der Heide A, Remme CA, Hofman DM, Jacobs JW, Bijlsma JW. Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis Rheum 1995;38:1466-74.
11. van Leeuwen MA, Westra J, van Riel PL, Limburg PC, van Rijswijk MH. IgM, IgA, and IgG rheumatoid factors in early rheumatoid arthritis predictive of radiological progression? Scand J Rheumatol 1995;24:146-53.
12. Farr M, Wainwright A, Salmon M, Hollywell CA, Bacon PA. Platelets in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int 1984;4:13-17.
13. Nordahl S, Alstergren P, Eliasson S, Kopp S. Radiographic signs of bone destruction in the arthritic temporomandibular joint with special reference to markers of disease activity. A longitudinal study. Rheumatology (Oxf) 2001;40:691-4.
14. Isomäki P, Punnonen J. Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Ann Med 1997;29:499-507.
15. Feldmann M, Brennan FM, Elliott MJ, Williams RO, Maini RN. TNF alpha is an effective therapeutic target for rheumatoid arthritis. Ann NY Acad Sci 1995;766:272-8.
16. Miossec P. The role of interleukin 1 in the pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol 1987;5:305-8.
17. Wong PK, Campbell IK, Egan PJ, Ernst M, Wicks IP. The role of the interleukin-6 family of cytokines in inflammatory arthritis and bone turnover. Arthritis Rheum 2003;48:1177-89.
18. Richardson BP, Engel G. The pharmacology and function of 5-HT3 receptors. Trends Neurosci 1986;9:424-8.
19. Endresen GK. Evidence for activation of platelets in the synovial fluid from patients with rheumatoid arthritis. Rheumatol Int 1989;9:19-24.
20. Cope AP, Aderka D, Doherty M, Engelmann H, Gibbons D, Jones AC, et al. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 1992;35:1160-9.
21. Jouvenne P, Vannier E, Dinarello CA, Miossec P. Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction. Arthritis Rheum 1998;41:1083-9.
22. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
23. Rohlin M, Åkerman S, Kopp S. Tomography as an aid to detect macroscopic changes of the temporomandibular joint. Acta Odontol Scand 1986;44:131-40.
24. Rohlin M, Petersson A. Rheumatoid arthritis of the temporomandibular joint: radiologic evaluation based on standard reference films. Oral Surg Oral Med Oral Pathol 1989;67:594-9.
25. Voog Ü, Alstergren P, Eliasson S, Leibur E, Kallikorm R, Kopp S. Inflammatory mediators and radiographic changes in temporomandibular joints of patients with rheumatoid arthritis. Acta Odontol Scand 2003;61:57-64.
26. Kaye RL. Other laboratory abnormalities. In: Katz WA, editor. Diagnosis and management of rheumatic diseases. Philadelphia: J. B. Lippincott; 1988. p. 244-7.
27. van der Heijde DM, van Riel PL, van Rijswijk MH, van de Putte LB. Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature. Semin Arthritis Rheum 1988;17:284-92.
28. Combe B, Eliaou JF, Daures JP, Meyer O, Clot J, Sany J. Prognostic factors in rheumatoid arthritis. Comparative study of two subsets of patients according to severity of articular damage. Br J Rheumatol 1995;34:529-34.
29. Elkon KB. Rheumatological laboratory tests. In: Paget SA, Gibofski A, Beary JF, editors. Manual of Rheumatology and outpatient orthopedic disorders. Diagnosis and therapy. Philadelphia: J. B. Lippincott; 2000. p. 14-22.
30. Combe B, Dougados M, Goupille P, Cantagrel A, Eliaou JF, Sibilia J, et al. Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study. Arthritis Rheum 2001;44:1736-43.
31. Rau R, Wassenberg S, Herborn G, Perschel WT, Freitag G. Identification of radiologic healing phenomena in patients with rheumatoid arthritis. J Rheumatol 2001;28:2608-15.
32. Alstergren P, Benavente C, Kopp S. Interleukin-1B, interleukin-1 receptor antagonist and interleukin-1 soluble receptor II in temporomandibular joint synovial fluid from patients with chronic polyarthritides. J Oral Maxillofac Surg 2003;61:1171-8.
33. Ballou SP, Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 1992;4:361-8.
34. Mohr W. Pathogenese der Gelenkzerstörung bei der chronischen polyarthritis. Radiologe 1996;36:593-9.
35. Olsen NJ, Teal GP, Brooks RH. IgM-rheumatoid factor and responses to second-line drugs in rheumatoid arthritis. Agents Actions 1991;34:169-71.
36. Stenger AA, Van Leeuwen MA, Houtman PM, Bruyn GA, Speerstra F, Barendsen BC, et al. Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression. Br J Rheumatol 1998;37:1157-63.
37. Tegelberg A, Kopp S, Huddenius K, Forssman L. Relationship between disorder in the stomatognathic system and general joint involvement in individuals with rheumatoid arthritis. Acta Odontol Scand 1987;45:391-8.
38. Dawson J, Engelhardt P, Kastelic T, Cheneval D, MacKenzie A, Ramage P. Effects of soluble interleukin-1 type II receptor on rabbit antigen-induced arthritis: clinical, biochemical and histological assessment. Rheumatology (Oxf) 1999;38:401-6.